Zachary Burnett, MD
Orthopedic Surgery · Saint Louis, MONPI 1871097568
Payments from drug & device makers
What this record shows
This record is dominated by grants: $37,500 of the $56,452 with a category attached, or 66.4%. Smith+Nephew accounts for 62.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $38,162 and has fallen 98.4% since, to $617 in 2025.
Across 28 payments — averaging $2016.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$35K
- Arthrex$20K
- Stryker$943
- Elite Orthopedics, LLC$237
- Zimmer Biomet$57
- Paragon 28, Inc.$41
- plus $146 from 6 others
What the payments were for
- Grants$37,50066%
- Food & beverage$1,4523%
- Education$17,50031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $35,027 |
| Arthrex | 1 | $20,000 |
| Stryker | 11 | $943 |
| Elite Orthopedics, LLC | 4 | $237 |
| Zimmer Biomet | 1 | $57 |
| Paragon 28, Inc. | 1 | $41 |
| Johnson & Johnson | 2 | $40 |
| Solventum Corporation | 1 | $31 |
| Heraeus Medical, LLC. | 1 | $25 |
| Curonix LLC | 1 | $22 |
| Bioventus LLC | 1 | $16 |
| Vericel Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopedic surgery providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 31 | $153 |
| Diclofenac Sodium | 13 | $135 |
| Oxycodone Hcl | 28 | $111 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Saint Louis
- Leo WhitesideSaint Louis$500K
- Richard LehmanSaint Louis$5K
- Daniel MartinSaint Louis$1K
- Alan MorrisSaint Louis$0
- Robert MarkensonSaint Louis$0
- John KrauseChesterfield$7K
- Steven SmithNorth Kansas City$4K
- Mitchell RotmanChesterfield$2K
- James ReardonNorth Kansas City$1K
- Hee LeeColumbia$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.